Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Monitoring Disease Progression with Stable Diffusion in Retinopathy of Prematurity
Author Affiliations & Notes
  • Sourav Kumar
    RADIOLOGY, Massachusetts General Hospital, Boston, Massachusetts, United States
    Electrical And Computer Engineering, Brown University, Providence, Rhode Island, United States
  • SHELL XU
    Samsung Research and Development, Cambridge, Cambridge, United Kingdom
  • AARON S COYNER
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Wei-Chun Lin
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Susan R Ostmo
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Deniz Erdogmus
    Electrical And Computer Enginerring, Northeastern University, Boston, Massachusetts, United States
  • Himanshu Tulip
    Engineering, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India
  • RV Paul Chan
    Opthalmology and Visual Sciences, University of Illinois Chicago, Chicago, Illinois, United States
  • Michael Chiang
    National Institutes of Health, Bethesda, Maryland, United States
  • J. Peter Campbell
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Jayashree Kalpathy-Cramer
    Opthalmology, University of Colorado System, Denver, Colorado, United States
  • Timothy Hospedales
    Samsung Research and Development, Cambridge, Cambridge, United Kingdom
  • Praveer Singh
    Opthalmology, University of Colorado System, Denver, Colorado, United States
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Footnotes
    Commercial Relationships   Sourav Kumar None; SHELL XU Samsung AI Research, Code E (Employment); AARON COYNER siloam vision, Code C (Consultant/Contractor), Boston AI Lab, Code R (Recipient); Wei-Chun Lin None; Susan Ostmo None; Deniz Erdogmus None; Himanshu Tulip None; RV Paul Chan Phoenix Technologies Group, Code C (Consultant/Contractor), Genentech, Code F (Financial Support), siloam, Code O (Owner), Boston AI Lab, Code R (Recipient); Michael Chiang None; J. Peter Campbell Boston AI Lab, Code C (Consultant/Contractor), Genentech, Code F (Financial Support), Siloam, Code O (Owner), Boston AI Lab, Code R (Recipient); Jayashree Kalpathy-Cramer Siloam, Code C (Consultant/Contractor), Genentech, Code F (Financial Support), Boston AI Lab, Code R (Recipient); Timothy Hospedales Samsung AI Research, Code E (Employment); Praveer Singh None
  • Footnotes
    Support  This work was supported by grants R01 EY019474, R01 EY031331, R21 EY031883, and P30 EY10572 from the National Institutes of Health (Bethesda, MD), and by unrestricted research grant to the Department of Ophthalmology, University of Colorado School of Medicine from Research to Prevent Blindness (New York, NY). The work was also supported in part by the Intramural Research Program, National Eye Institute
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5653. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sourav Kumar, SHELL XU, AARON S COYNER, Wei-Chun Lin, Susan R Ostmo, Deniz Erdogmus, Himanshu Tulip, RV Paul Chan, Michael Chiang, J. Peter Campbell, Jayashree Kalpathy-Cramer, Timothy Hospedales, Praveer Singh; Monitoring Disease Progression with Stable Diffusion in Retinopathy of Prematurity. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5653.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinopathy of Prematurity (ROP) is the leading cause of childhood blindness in premature infants. While only 5-10% of total cases progress to severe ROP, it is quintessential to understand the physiology & progression of ROP, for early diagnosis & effective & timely treatment. In this study, we leverage a Stable Diffusion (SD) model to build a class-conditioned ROP image generation tool & further combine it with image editing techniques to enable easy transformation of disease severity for a given ROP image

Methods : We cast the problem of visualizing ROP progression as an image editing problem. Given an input image of any of the Normal/Pre-Plus/Plus class, the goal is to transform it into another class, while preserving the global structure & some local attributes so that the transformed image is still perceived as an image belonging to the same patient. We first fine-tune a Text-to-Image SD model on the iROP dataset (5500 images), thus allowing the model to generate realistic images of each class prompted by textual inputs. We next employ two image editing techniques: Null Text Inversion & Prompt-to-Prompt Image Editing, essentially allowing image modification through attention reweighting (Fig.1) during the forward diffusion process. To evaluate SD-based image generation, we calculate Frechet Inception Distance (FID) score between real & generated images as well as Plus disease classifier accuracy when tested on class-conditioned generated images. To evaluate image editing, we calculate correlation between ROP Vascular Severity Score (VSS) of a generated image & real image of increased severity for the same normal image.

Results : Our SD model achieves FID scores of 92, 114, and 137 for Normal, Pre-Plus, & Plus classes, respectively. We achieve 97% accuracy for generated plus class when tested with a Plus Classifier model. A correlation of 0.97 between ROP VSS of generated & real images indicates proportional attention weight adjustment enables the generation of required severity images

Conclusions : Our SD-based image editing tool allows easy visualization of the severity of the disease at a future date on new data samples, which may have no disease development yet or are at a moderate severity stage of the disease. This can provide clinicians with valuable insights into the potential progression of the disease & aid in early diagnosis & treatment, ultimately improving outcomes for premature infants.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×